Fig. 1.

Correlation of CCR-5 Δ32 minor allele prevalence with the number of COVID-19 infection cases/million and the number of patients death due to COVID-19/million worldwide. Prevalence of CCR-5 Δ32 mutant allele in healthy controls was searched from earlier published reports and correlated with COVID-19 infection (A) and death rate (B) per million throughout the globe. Each dot represented a country. A positive correlation was observed in the distribution of CCR-5 Δ32 minor allele with the number of cases (Spearman r = 0.4628, p < 0.0001, n = 107) and death (Spearman r = 0.5517, p < 0.0001, n = 107) from COVID-19. A total of one hundred seven countries were considered for the analysis based on availability of data. The list of countries are follows “Afghanistan, Albania, Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Burkina Faso, Cameroon, Canada, Chile, China, Colombia, Croatia, Cuba, Cyprus, Czech Republic, DR Congo, Denmark, Dominican Republic, Ecuador, Egypt, El Salvador, Eritrea, Estonia, Ethiopia, Faeroe Islands, Finland, France, Georgia, Germany, Ghana, Greece, Guinea, Hong Kong, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Ivory Coast, Jamaica, Japan, Jordan, Kazakhstan, Kenya, Kosovo, Kyrgyzstan, Latvia, Lebanon, Lithuania, Luxembourg, Malawi, Malta, Mexico, Moldova, Mongolia, Montenegro, Morocco, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Papua New Guinea, Peru, Philippines, Poland, Portugal, Romania, Russia, Rwanda, Saudi Arabia, Senegal, Serbia, Slovakia, Slovenia, Somalia, South Africa, South Korea, Spain, Sri Lanka, Sweden, Switzerland, Syria, Taiwan, Thailand, Tunisia, Turkey, Ukraine, United Arab Emirates, United Kingdom, United State, Venezuela, Vietnam”.